Search
Spyre Therapeutics Inc
SYREAdd to Watchlist
86.630USD
-2.260-2.54%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
6.77BMarket Cap
LossP/E TTM
Spyre Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-2.42
45.22%
Analyst Rating
STRONG BUY
2026-07-04
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What are the current assets of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its current assets were 777.78M, with a year-on-year change of 27.82.
What are the total assets of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its total assets of Spyre Therapeutics Inc were 777.78M, with a year-on-year change of 27.82.
What are the total liabilities of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its total liabilities of Spyre Therapeutics Inc were 62.55M, with a year-on-year change of -31.03.
What is the total equity of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its total equity of Spyre Therapeutics Inc was 715.24M, with a year-on-year change of 38.13.
What is the net investment of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its net investment of Spyre Therapeutics Inc was -143.47M, with a year-on-year change of 59.39.
What is the net financing of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its net financing of Spyre Therapeutics Inc was 309.02M, with a year-on-year change of -24.79.
What is the Earnings Per Share (EPS) of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.42, with a year-on-year change of 45.22.
What is the Return on Equity (ROE) of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -33.69, with a year-on-year change of 70.76.
What is the Return on Assets (ROA) of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -22.39, with a year-on-year change of 48.85.
What is the operating profit of Spyre Therapeutics Inc?
According to Spyre Therapeutics Inc's FY2025 earnings report, its operating profit was -219.56M, with a year-on-year change of -5.27.